Tenax Therapeutics Announces Closing of $10 Million Underwritten Offering Business Wire
Tenax Therapeutics, Inc. (Nasdaq: TENX) announces closing of an underwritten offering for gross proceeds of approximately $10 million.
Tenax Therapeutics Announces Closing of $10 Million Underwritten Offering Business Wire
Tenax Therapeutics, Inc. (Nasdaq: TENX) announces closing of an underwritten offering for gross proceeds of approximately $10 million.